LAUROYL PEG-32 GLYCERIDES
Substance profile for UNII H5ZC52369M, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Substance Identity#
- UNII
- H5ZC52369M
- Preferred term
- LAUROYL PEG-32 GLYCERIDES
- Registry number
- 121548-04-7
- Ingredient type
- INGREDIENT SUBSTANCE
Chemical And Database Identifiers#
- RxCUI
- 1597625
- PubChem
- 0
- INN ID
- 0
Open Chemistry Sources#
| Source | Identifier | Link |
|---|---|---|
| RxNorm | 1597625 |  mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1597625 |
| FDA Substance Registration System | H5ZC52369M |  precision.fda.gov/uniisearch/srs/unii/H5ZC52369M |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LAUROYL PEG-32 GLYCERIDES | INACTIVE INGREDIENT | H5ZC52369M | FINASTERIDE TABLET, FILM COATED [ACCORD HEALTHCARE, INC.] | 5 | |
| LAUROYL PEG-32 GLYCERIDES | INACTIVE INGREDIENT | H5ZC52369M | FINASTERIDE TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] | 3 | |
| LAUROYL PEG-32 GLYCERIDES | INACTIVE INGREDIENT | H5ZC52369M | LYNPARZA (OLAPARIB) CAPSULE [ASTRAZENECA PHARMACEUTICALS LP] | 2 |
Inactive Ingredient Database#
| Ingredient | UNII | CAS | Dosage form | Route | Potency | Maximum daily exposure |
|---|---|---|---|---|---|---|
| LAUROYL PEG-32 GLYCERIDES | H5ZC52369M | 121548047 | CAPSULE | ORAL | 7200 mg | |
| LAUROYL PEG-32 GLYCERIDES | H5ZC52369M | 121548047 | TABLET | ORAL | 0.15 mg |